Clinical Trial Update: Camrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating camrelizumab combined with SOX and/or apatinib for locally advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• SOX (SOX)

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Locally Advanced Gastric Cancer | Phase 2 | Status: UNKNOWN